Pregnancy feasible for heart recipientsBut better counselling needed on drug risks and long-term maternal survival Antiplatelet agents unaffected by proton pump inhibitors Resynchronization slows heart failure progression But study results leave cardiologists wrestling with questions of cost and patient selection Doubling clopidogrel dose makes for safer angioplasty Decrease in heart attack and thrombosis risk outweighs rise in severe bleeding: Canadian study New antiplatelet agent reduces cardiovascular events Getting to the heart of it Community management of the post-myocardial infarction patient. Clinical Feature: Dysplipidemia A look at current issues and what’s new in management. What are the causes and treatments for anemia of chronic disease? What are the causes and drug treatments for “anemia of chronic disease” and anemia resulting from chronic renal failure? The gender divide: heart failure differs in women Physicians should be aware of variance in symptoms, age at onset and comorbidities in female patients Ontario study reheats rosiglitazone controversy Research recommends avoiding the medication due to cardiovascular risks First Previous 93 94 95 96 97 Next Last
